Xu Yu Chen, Wang Qiu Qin, Chen Meng Yuan, Gao Yu Jie, Wang Jia Yi, Ge Hao Tian, Weng Heng, Chen Ju Ping, Xu Gui Hua
School of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
Department of Neurology, Changshu Hospital of Traditional Chinese Medicine, Suzhou, 215500, People's Republic of China.
Int J Gen Med. 2024 Jun 14;17:2791-2800. doi: 10.2147/IJGM.S461958. eCollection 2024.
Pain is a common yet undertreated symptom of Parkinson's disease (PD). This study investigated the effect of Gua Sha therapy on pain in patients with PD.
A total of 56 PD patients with pain were randomized into either the experimental group (n=28), receiving 12 sessions of Gua Sha therapy, or the control group (n=28) without additional treatment. Participants underwent assessment at baseline, after the twelfth invention, and at the 2-month follow-up timepoints. The primary outcome was KPPS and VAS. Secondary outcomes included UPDRS I-III, PDSS-2, HADS, PDQ-39, and blood biomarkers (5-HT, IL-8, IL-10).
The experimental group reported a significant improvement in pain severity, motor functions, affective disorder, and sleep quality ( < 0.05). Furthermore, increasing trends in both 5-HT and IL-10, as well as decreasing trends in IL-8 were observed. No serious adverse events occurred.
The preliminary findings suggest that Gua Sha therapy may be effective and safe for alleviating pain and improving other disease-related symptoms in PD patients.
疼痛是帕金森病(PD)常见但未得到充分治疗的症状。本研究调查了刮痧疗法对PD患者疼痛的影响。
总共56名有疼痛症状的PD患者被随机分为实验组(n = 28),接受12次刮痧治疗,或对照组(n = 28),不接受额外治疗。参与者在基线、第12次治疗后以及2个月随访时间点接受评估。主要结局指标为韩国疼痛量表(KPPS)和视觉模拟评分法(VAS)。次要结局指标包括帕金森病统一评分量表(UPDRS)I - III、帕金森病睡眠量表第二版(PDSS - 2)、医院焦虑抑郁量表(HADS)、帕金森病问卷39项版(PDQ - 39)以及血液生物标志物(5 - 羟色胺、白细胞介素 - 8、白细胞介素 - 10)。
实验组在疼痛严重程度、运动功能、情感障碍和睡眠质量方面有显著改善(P < 0.05)。此外,观察到5 - 羟色胺和白细胞介素 - 10均有上升趋势,白细胞介素 - 8有下降趋势。未发生严重不良事件。
初步研究结果表明,刮痧疗法可能对缓解PD患者的疼痛及改善其他疾病相关症状有效且安全。